IO Biotech to Present at the Jefferies Healthcare Conference
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
News
IO Biotech to Present at the Jefferies Healthcare Conference
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Monte Rosa Therapeutics to Present at Upcoming Investor and Industry Conferences
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology…
Monte Rosa Therapeutics to Present at Upcoming Investor and Industry Conferences
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology…
Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aceragen, Inc. (the “Company”)…
Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aceragen, Inc. (the “Company”)…
AnaptysBio Announces Participation in Upcoming Investor Conferences
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
AnaptysBio Announces Participation in Upcoming Investor Conferences
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
Landos Biopharma Expands Board of Directors with Appointment of Alka Batycky, Ph.D.
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage…
Landos Biopharma Expands Board of Directors with Appointment of Alka Batycky, Ph.D.
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage…
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader
Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and…
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader
Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and…
PepGen Inc. Announces Clinical Hold in the U.S. on IND Application to Initiate a Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company…
PepGen Inc. Announces Clinical Hold in the U.S. on IND Application to Initiate a Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company…
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares and Warrants
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or…
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares and Warrants
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or…
Sumo Logic Provides Cloud-Native Log Analytics for Samsung Electronics Bixby Virtual AI Assistant
Samsung and Sumo Logic Sumo Logic Provides Cloud-Native Log Analytics for Samsung Electronics Bixby Virtual…
Sumo Logic Provides Cloud-Native Log Analytics for Samsung Electronics Bixby Virtual AI Assistant
Samsung and Sumo Logic Sumo Logic Provides Cloud-Native Log Analytics for Samsung Electronics Bixby Virtual…
Deveron Reports $5.36 Million in Revenue in Q1/2023, up 281% Year-Over-Year
Toronto, Ontario–(Newsfile Corp. – May 30, 2023) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
Justera Health Reports Q1 Financial Results
Toronto, Ontario–(Newsfile Corp. – May 30, 2023) – Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro…